Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ProScreen, Protein Signature Based Screening of Colorectal Adenomas and Cancer

NCT07881549 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT07881549
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07881549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ProScreen, Protein Signature Based Screening of Colorectal Adenomas and Cancer
Lead sponsor
Region Skane
Phase
Observational
Overall status
Enrolling by invitation
Start date
October 9, 2026
Completion date
March 31, 2028
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal adenoma, colorectal cancer